Pemetrexed plus Platinum Chemotherapy with or Without Immuno Responses of Bevacizumab plus Cisplatin for the Non-Squamous Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusions Therapy in Non-Squamous NSCLC: Descriptive Safety Analysis

被引：0
|
作者：
Li, X.
Li, J.
机构：
[1] Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Med Oncol, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
bevacizumab; Cisplatin; malignant pleural effusion;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-041
引用
收藏
页码：S2084 / S2084
页数：1
相关论文
共 50 条
  • [31] Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer
    Koba, Taro
    Minami, Seigo
    Nishijima-Futami, Yu
    Masuhiro, Kentaro
    Kimura, Hiromi
    Futami, Shinji
    Yaga, Moto
    Mori, Masahide
    Kagawa, Hiroyuki
    Uenami, Takeshi
    Kohmo, Satoshi
    Otsuka, Tomoyuki
    Yamamoto, Suguru
    Komuta, Kiyoshi
    Kijima, Takashi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (01) : 111 - 117
  • [32] Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer
    Taro Koba
    Seigo Minami
    Yu Nishijima-Futami
    Kentaro Masuhiro
    Hiromi Kimura
    Shinji Futami
    Moto Yaga
    Masahide Mori
    Hiroyuki Kagawa
    Takeshi Uenami
    Satoshi Kohmo
    Tomoyuki Otsuka
    Suguru Yamamoto
    Kiyoshi Komuta
    Takashi Kijima
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 111 - 117
  • [33] EFFICACY AND SURVIVAL DATA FROM A PHASE II STUDY OF HISTOLOGY-GUIDED CHEMOTHERAPY IN STAGE IIIB/IV NON-SMALL CELL LUNG CANCER WITH PEMETREXED PLUS PLATINUM FOR NON-SQUAMOUS AND TAXANE PLUS PLATINUM FOR SQUAMOUS AND NON-SQUAMOUS CARCINOMAS
    Sunpaweravong, Patrapim
    Dechaphunkul, Arunee
    Nirattisaikul, Sitang
    Kayasuy, Kanita
    Viriyachaiyo, Vilaiwan
    Juthong, Siwasak
    Keeratichananont, Warangkana
    Navasakulpong, Asma
    Kamonmarttayakul, Katekanok
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1315 - S1315
  • [34] COST COMPARISON OF BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE VERSUS PEMETREXED AND CISPLATIN THERAPY IN PATIENTS WITH ADVANCED OR RECURRENT NON-SQUAMOUS NON-SMALL CELL CANCER IN GERMANY - AN UPDATED ANALYSIS
    Bischoff, H. G.
    Hermes, A.
    Heigener, D. F.
    Cesaro-Tadic, S.
    Walzer, S.
    Nuijten, M.
    VALUE IN HEALTH, 2010, 13 (03) : A39 - A39
  • [35] Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
    Fujimoto, Daichi
    Miura, Satoru
    Tomii, Keisuke
    Sumikawa, Hiromitsu
    Yoshimura, Kenichi
    Wakuda, Kazushige
    Oya, Yuko
    Yokoyama, Toshihide
    Kijima, Takashi
    Asao, Tetsuhiko
    Tamiya, Motohiro
    Nakamura, Atsushi
    Yoshioka, Hiroshige
    Tokito, Takaaki
    Murakami, Shuji
    Tamiya, Akihiro
    Yokouchi, Hiroshi
    Watanabe, Satoshi
    Yamaguchi, Ou
    Morinaga, Ryotaro
    Jodai, Takayuki
    Ito, Kentaro
    Shiraishi, Yoshimasa
    Kogure, Yoshihito
    Shibaki, Ryota
    Yamamoto, Nobuyuki
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [36] Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
    Daichi Fujimoto
    Satoru Miura
    Keisuke Tomii
    Hiromitsu Sumikawa
    Kenichi Yoshimura
    Kazushige Wakuda
    Yuko Oya
    Toshihide Yokoyama
    Takashi Kijima
    Tetsuhiko Asao
    Motohiro Tamiya
    Atsushi Nakamura
    Hiroshige Yoshioka
    Takaaki Tokito
    Shuji Murakami
    Akihiro Tamiya
    Hiroshi Yokouchi
    Satoshi Watanabe
    Ou Yamaguchi
    Ryotaro Morinaga
    Takayuki Jodai
    Kentaro Ito
    Yoshimasa Shiraishi
    Yoshihito Kogure
    Ryota Shibaki
    Nobuyuki Yamamoto
    Scientific Reports, 13
  • [37] CLINICAL INVESTIGATION OF CISPLATINE/PEMETREXED IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
    Watanabe, K.
    Okuma, Y.
    Nakahara, Y.
    Yomota, M.
    Takagi, Y.
    Hosomi, Y.
    Okamura, T.
    ANNALS OF ONCOLOGY, 2013, 24 : 86 - 86
  • [38] Efficacy and safety of bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer (NSCLC)
    Tassinari, D.
    Drudi, F.
    Carloni, F.
    Nicoletti, S.
    Possenti, C.
    Santelmo, C.
    Lazzari, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] PD-1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in patients with advanced non-squamous non-small-cell lung cancer: a pooled analysis of three randomised trials
    Meng, Xiangjiao
    Chen, Yu
    Xing, Ligang
    Liu, Xinchao
    Zhao, Kaikai
    Jiang, Liyang
    Zhang, Li
    Zhou, Caicun
    Yu, Jinming
    BMJ OPEN RESPIRATORY RESEARCH, 2022, 9 (01)
  • [40] Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
    Stathopoulos, G. P.
    Antoniou, D.
    Dimitroulis, J.
    Stathopoulos, J.
    Marosis, K.
    Michalopoulou, P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (04) : 945 - 950
12345